Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthew P Giannetti

Showing results (11-20 of 18) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 18 results.
Diagnostics (Basel, Switzerland)|January 22, 2024
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in MastocytosisMatthew P Giannetti, Jennifer Nicoloro-SantaBarbara, Grace Godwin, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2020
Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphologyMatthew P Giannetti, Cem Akin, Raied Hufdhi, et al.
The American Journal of Surgical Pathology|January 22, 2021
Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation SyndromeMatthew J Hamilton, Melissa Zhao, Matthew P Giannetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2022
Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndromePeter Novak, Matthew P Giannetti, Emily Weller, et al.
American Journal of Medicine Open|August 22, 2025
Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic FeaturesPeter Novak, David M Systrom, Sadie P Marciano, et al.
The Journal of Allergy and Clinical Immunology|June 8, 2024
Mast cell activation syndrome: Current understanding and research needsMariana Castells, Matthew P Giannetti, Matthew J Hamilton, et al.
Science Immunology|February 27, 2021
Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammationDaniel F Dwyer, Jose Ordovas-Montanes, Samuel J Allon, et al.
NEJM Evidence|February 6, 2024
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.
Pageof 2

Showing results (11-20 of 18) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 18 results.
Diagnostics (Basel, Switzerland)|January 22, 2024
Challenges in Drug and Hymenoptera Venom Hypersensitivity Diagnosis and Management in MastocytosisMatthew P Giannetti, Jennifer Nicoloro-SantaBarbara, Grace Godwin, et al.
The Journal of Allergy and Clinical Immunology|November 28, 2020
Patients with mast cell activation symptoms and elevated baseline serum tryptase level have unique bone marrow morphologyMatthew P Giannetti, Cem Akin, Raied Hufdhi, et al.
The American Journal of Surgical Pathology|January 22, 2021
Distinct Small Intestine Mast Cell Histologic Changes in Patients With Hereditary Alpha-tryptasemia and Mast Cell Activation SyndromeMatthew J Hamilton, Melissa Zhao, Matthew P Giannetti, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|September 28, 2022
Network autonomic analysis of post-acute sequelae of COVID-19 and postural tachycardia syndromePeter Novak, Matthew P Giannetti, Emily Weller, et al.
American Journal of Medicine Open|August 22, 2025
Hypermobile Ehlers-Danlos Syndrome: Cerebrovascular, Autonomic and Neuropathic FeaturesPeter Novak, David M Systrom, Sadie P Marciano, et al.
The Journal of Allergy and Clinical Immunology|June 8, 2024
Mast cell activation syndrome: Current understanding and research needsMariana Castells, Matthew P Giannetti, Matthew J Hamilton, et al.
Science Immunology|February 27, 2021
Human airway mast cells proliferate and acquire distinct inflammation-driven phenotypes during type 2 inflammationDaniel F Dwyer, Jose Ordovas-Montanes, Samuel J Allon, et al.
NEJM Evidence|February 6, 2024
Avapritinib versus Placebo in Indolent Systemic MastocytosisJason Gotlib, Mariana Castells, Hanneke Oude Elberink, et al.
Pageof 2